AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. NUWE
  4. [8-K] Nuwellis, Inc. Reports Material Event

[8-K] Nuwellis, Inc. Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

Nuwellis has received a delisting notice from Nasdaq on June 18, 2025, due to non-compliance with the minimum bid price requirement of $1.00 for 30 consecutive trading days. The company is not eligible for the standard compliance period due to previous reverse stock splits.

Key developments:

  • Company executed a reverse stock split on June 27, 2024
  • Shareholders approved a new reverse split ratio of 1-for-5 to 1-for-70 at May 20, 2025 annual meeting
  • Board intends to implement another reverse stock split to regain compliance
  • Company plans to request a hearing with Nasdaq Hearings Panel

Stock will remain listed on Nasdaq Capital Market pending the hearing outcome. However, there is no guarantee of continued listing or successful compliance restoration. This situation presents significant risks for investors, including potential delisting and further share dilution through another reverse split.

Nuwellis ha ricevuto una notifica di esclusione dal Nasdaq il 18 giugno 2025, a causa del mancato rispetto del requisito minimo del prezzo di offerta di 1,00 $ per 30 giorni di negoziazione consecutivi. La societ脿 non 猫 idonea al periodo standard di conformit脿 a causa di precedenti frazionamenti inversi delle azioni.

Sviluppi chiave:

  • La societ脿 ha eseguito un frazionamento inverso il 27 giugno 2024
  • Gli azionisti hanno approvato un nuovo rapporto di frazionamento inverso da 1-per-5 a 1-per-70 durante l'assemblea annuale del 20 maggio 2025
  • Il consiglio intende attuare un ulteriore frazionamento inverso per ristabilire la conformit脿
  • La societ脿 prevede di richiedere un'udienza al Nasdaq Hearings Panel

Le azioni rimarranno quotate sul Nasdaq Capital Market in attesa dell'esito dell'udienza. Tuttavia, non vi 猫 alcuna garanzia di mantenere la quotazione o di ripristinare con successo la conformit脿. Questa situazione comporta rischi significativi per gli investitori, inclusa la possibilit脿 di esclusione dalla quotazione e ulteriore diluizione delle azioni tramite un altro frazionamento inverso.

Nuwellis ha recibido un aviso de exclusi贸n de Nasdaq el 18 de junio de 2025, debido al incumplimiento del requisito m铆nimo de precio de oferta de $1.00 durante 30 d铆as h谩biles consecutivos. La compa帽铆a no es elegible para el per铆odo est谩ndar de cumplimiento debido a anteriores divisiones inversas de acciones.

Desarrollos clave:

  • La empresa realiz贸 una divisi贸n inversa el 27 de junio de 2024
  • Los accionistas aprobaron una nueva proporci贸n de divisi贸n inversa de 1 a 5 hasta 1 a 70 en la reuni贸n anual del 20 de mayo de 2025
  • La junta tiene la intenci贸n de implementar otra divisi贸n inversa para recuperar el cumplimiento
  • La empresa planea solicitar una audiencia ante el Panel de Audiencias de Nasdaq

Las acciones permanecer谩n listadas en el Nasdaq Capital Market mientras se espera el resultado de la audiencia. Sin embargo, no hay garant铆a de mantener la cotizaci贸n o de restaurar el cumplimiento con 茅xito. Esta situaci贸n representa riesgos significativos para los inversores, incluyendo la posible exclusi贸n y una mayor diluci贸n de acciones mediante otra divisi贸n inversa.

Nuwellis電� 2025雲� 6鞗� 18鞚�, 30瓯半灅鞚� 鞐办啀鞙茧 斓滌唽 鞛呾鞍臧� $1.00 氙鸽嫭靹膘溂搿� 鞚疙暣 雮橃姢雼レ溂搿滊秬韯� 靸侅灔韽愳 韱惦炒毳� 氚涭晿鞀惦媹雼�. 鞚挫爠 鞐＜鞁濍秳頃犽 鞚疙暣 響滌 欷�靾� 旮瓣皠 鞝侅毄 雽�靸侅澊 鞎勲嫏雼堧嫟.

欤检殧 歆勴枆 靷暛:

  • 須岇偓電� 2024雲� 6鞗� 27鞚� 鞐＜鞁濍秳頃犾潉 鞁れ嫓頃�
  • 欤检＜霌れ潃 2025雲� 5鞗� 20鞚� 鞐半 須岇潣鞐愳劀 1雽� 5鞐愳劀 1雽� 70旯岇 靸堧鞖� 鞐＜鞁濍秳頃� 牍勳湪鞚� 鞀轨澑頃�
  • 鞚挫偓須岆姅 欷�靾� 須岆车鞚� 鞙勴暣 於旉皜 鞐＜鞁濍秳頃犾潉 鞁滍枆頃� 瓿勴殟鞛�
  • 須岇偓電� 雮橃姢雼� 觳須� 韺剱鞐� 觳 鞖旍箔鞚� 瓿勴殟 欷戩瀯

欤检嫕鞚� 觳 瓴瓣臣毳� 旮半嫟毽姅 霃欖晥 雮橃姢雼� 旌愴敿韮� 毵堨紦鞐� 靸侅灔 鞙犾霅╇媹雼�. 攴鸽煬雮� 歆�靻嶌爜鞚� 靸侅灔 鞙犾雮� 靹标车鞝侅澑 欷�靾� 須岆车鞚� 氤挫灔霅橃 鞎婌姷雼堧嫟. 鞚� 靸來櫓鞚� 韴瀽鞛愳棎瓴� 靸侅灔韽愳 臧�電レ劚瓿� 於旉皜 鞐＜鞁濍秳頃犾棎 霐半ジ 欤检嫕 頋劃 鞙勴棙 霌� 欷戨寑頃� 鞙勴棙鞚� 雮错彫頃╇媹雼�.

Nuwellis a re莽u un avis de radiation de la part du Nasdaq le 18 juin 2025, en raison du non-respect de l'exigence de prix minimum de l'offre de 1,00 $ pendant 30 jours de bourse cons茅cutifs. La soci茅t茅 n'est pas 茅ligible 脿 la p茅riode de conformit茅 standard en raison de pr茅c茅dentes divisions inverses d'actions.

Faits marquants :

  • La soci茅t茅 a effectu茅 une division inverse le 27 juin 2024
  • Les actionnaires ont approuv茅 un nouveau ratio de division inverse de 1 pour 5 脿 1 pour 70 lors de l'assembl茅e annuelle du 20 mai 2025
  • Le conseil d'administration pr茅voit de mettre en 艙uvre une autre division inverse pour retrouver la conformit茅
  • La soci茅t茅 envisage de demander une audience aupr猫s du Nasdaq Hearings Panel

Les actions resteront cot茅es sur le Nasdaq Capital Market en attendant l'issue de l'audience. Cependant, il n'y a aucune garantie de maintien de la cotation ou de r茅tablissement r茅ussi de la conformit茅. Cette situation pr茅sente des risques importants pour les investisseurs, notamment la possibilit茅 de radiation et une dilution suppl茅mentaire des actions via une autre division inverse.

Nuwellis hat am 18. Juni 2025 eine Mitteilung 眉ber die Delistung von der Nasdaq erhalten, da die Mindestgebotspreisanforderung von 1,00 $ f眉r 30 aufeinanderfolgende Handelstage nicht erf眉llt wurde. Das Unternehmen ist aufgrund vorheriger Reverse Stock Splits nicht f眉r die Standard-Compliance-Periode berechtigt.

Wichtige Entwicklungen:

  • Das Unternehmen f眉hrte am 27. Juni 2024 einen Reverse Stock Split durch
  • Die Aktion盲re genehmigten auf der Hauptversammlung am 20. Mai 2025 ein neues Reverse-Split-Verh盲ltnis von 1:5 bis 1:70
  • Der Vorstand beabsichtigt, einen weiteren Reverse Stock Split durchzuf眉hren, um die Compliance wiederherzustellen
  • Das Unternehmen plant, eine Anh枚rung beim Nasdaq Hearings Panel zu beantragen

Die Aktie bleibt bis zum Ergebnis der Anh枚rung an der Nasdaq Capital Market notiert. Es gibt jedoch keine Garantie f眉r eine fortgesetzte Notierung oder die erfolgreiche Wiederherstellung der Compliance. Diese Situation birgt erhebliche Risiken f眉r Investoren, einschlie脽lich einer m枚glichen Delistung und weiterer Verw盲sserung der Aktien durch einen weiteren Reverse Split.

Positive
  • None.
Negative
  • Received Nasdaq delisting notice due to stock price falling below $1.00 for 30 consecutive trading days
  • Company not eligible for standard compliance period due to previous reverse stock split within past year
  • Immediate delisting risk - must request hearing to maintain temporary listing status
  • Previous reverse stock split in June 2024 failed to maintain required price levels, indicating deeper fundamental issues
  • Company plans another reverse split (1-for-5 to 1-for-70 range) despite recent split, suggesting continued share price weakness

Insights

Nuwellis faces potential Nasdaq delisting due to sub-$1 share price despite a 2024 reverse split; another split planned but compliance uncertain.

Nuwellis has received a Nasdaq delisting notice for failing to maintain the minimum $1 bid price requirement for 30 consecutive trading days. What makes this situation particularly concerning is that the company is ineligible for the standard compliance period because it already executed a reverse stock split on June 27, 2024 - less than a year ago.

The company has outlined a two-part strategy to maintain its listing: requesting a hearing with the Nasdaq Hearings Panel and implementing another reverse stock split. Shareholders have already approved a potential split ranging from 1-for-5 to 1-for-70 at their May 20, 2025 annual meeting, giving the board significant flexibility in determining the ratio.

While shares will continue trading on Nasdaq during the hearing process, the filing explicitly acknowledges uncertainty about the outcome, stating "there can be no assurance that the Panel will grant the Company's request for continued listing or that the Company will be able to regain compliance."

The need for a second reverse split within approximately one year represents a significant concern. The wide range of the approved split ratio (up to 1-for-70) indicates the board is preparing for potentially drastic action to lift the share price above compliance thresholds. If delisted, shareholders would face reduced liquidity, institutional ownership limitations, and decreased market visibility through over-the-counter trading.

Nuwellis ha ricevuto una notifica di esclusione dal Nasdaq il 18 giugno 2025, a causa del mancato rispetto del requisito minimo del prezzo di offerta di 1,00 $ per 30 giorni di negoziazione consecutivi. La societ脿 non 猫 idonea al periodo standard di conformit脿 a causa di precedenti frazionamenti inversi delle azioni.

Sviluppi chiave:

  • La societ脿 ha eseguito un frazionamento inverso il 27 giugno 2024
  • Gli azionisti hanno approvato un nuovo rapporto di frazionamento inverso da 1-per-5 a 1-per-70 durante l'assemblea annuale del 20 maggio 2025
  • Il consiglio intende attuare un ulteriore frazionamento inverso per ristabilire la conformit脿
  • La societ脿 prevede di richiedere un'udienza al Nasdaq Hearings Panel

Le azioni rimarranno quotate sul Nasdaq Capital Market in attesa dell'esito dell'udienza. Tuttavia, non vi 猫 alcuna garanzia di mantenere la quotazione o di ripristinare con successo la conformit脿. Questa situazione comporta rischi significativi per gli investitori, inclusa la possibilit脿 di esclusione dalla quotazione e ulteriore diluizione delle azioni tramite un altro frazionamento inverso.

Nuwellis ha recibido un aviso de exclusi贸n de Nasdaq el 18 de junio de 2025, debido al incumplimiento del requisito m铆nimo de precio de oferta de $1.00 durante 30 d铆as h谩biles consecutivos. La compa帽铆a no es elegible para el per铆odo est谩ndar de cumplimiento debido a anteriores divisiones inversas de acciones.

Desarrollos clave:

  • La empresa realiz贸 una divisi贸n inversa el 27 de junio de 2024
  • Los accionistas aprobaron una nueva proporci贸n de divisi贸n inversa de 1 a 5 hasta 1 a 70 en la reuni贸n anual del 20 de mayo de 2025
  • La junta tiene la intenci贸n de implementar otra divisi贸n inversa para recuperar el cumplimiento
  • La empresa planea solicitar una audiencia ante el Panel de Audiencias de Nasdaq

Las acciones permanecer谩n listadas en el Nasdaq Capital Market mientras se espera el resultado de la audiencia. Sin embargo, no hay garant铆a de mantener la cotizaci贸n o de restaurar el cumplimiento con 茅xito. Esta situaci贸n representa riesgos significativos para los inversores, incluyendo la posible exclusi贸n y una mayor diluci贸n de acciones mediante otra divisi贸n inversa.

Nuwellis電� 2025雲� 6鞗� 18鞚�, 30瓯半灅鞚� 鞐办啀鞙茧 斓滌唽 鞛呾鞍臧� $1.00 氙鸽嫭靹膘溂搿� 鞚疙暣 雮橃姢雼レ溂搿滊秬韯� 靸侅灔韽愳 韱惦炒毳� 氚涭晿鞀惦媹雼�. 鞚挫爠 鞐＜鞁濍秳頃犽 鞚疙暣 響滌 欷�靾� 旮瓣皠 鞝侅毄 雽�靸侅澊 鞎勲嫏雼堧嫟.

欤检殧 歆勴枆 靷暛:

  • 須岇偓電� 2024雲� 6鞗� 27鞚� 鞐＜鞁濍秳頃犾潉 鞁れ嫓頃�
  • 欤检＜霌れ潃 2025雲� 5鞗� 20鞚� 鞐半 須岇潣鞐愳劀 1雽� 5鞐愳劀 1雽� 70旯岇 靸堧鞖� 鞐＜鞁濍秳頃� 牍勳湪鞚� 鞀轨澑頃�
  • 鞚挫偓須岆姅 欷�靾� 須岆车鞚� 鞙勴暣 於旉皜 鞐＜鞁濍秳頃犾潉 鞁滍枆頃� 瓿勴殟鞛�
  • 須岇偓電� 雮橃姢雼� 觳須� 韺剱鞐� 觳 鞖旍箔鞚� 瓿勴殟 欷戩瀯

欤检嫕鞚� 觳 瓴瓣臣毳� 旮半嫟毽姅 霃欖晥 雮橃姢雼� 旌愴敿韮� 毵堨紦鞐� 靸侅灔 鞙犾霅╇媹雼�. 攴鸽煬雮� 歆�靻嶌爜鞚� 靸侅灔 鞙犾雮� 靹标车鞝侅澑 欷�靾� 須岆车鞚� 氤挫灔霅橃 鞎婌姷雼堧嫟. 鞚� 靸來櫓鞚� 韴瀽鞛愳棎瓴� 靸侅灔韽愳 臧�電レ劚瓿� 於旉皜 鞐＜鞁濍秳頃犾棎 霐半ジ 欤检嫕 頋劃 鞙勴棙 霌� 欷戨寑頃� 鞙勴棙鞚� 雮错彫頃╇媹雼�.

Nuwellis a re莽u un avis de radiation de la part du Nasdaq le 18 juin 2025, en raison du non-respect de l'exigence de prix minimum de l'offre de 1,00 $ pendant 30 jours de bourse cons茅cutifs. La soci茅t茅 n'est pas 茅ligible 脿 la p茅riode de conformit茅 standard en raison de pr茅c茅dentes divisions inverses d'actions.

Faits marquants :

  • La soci茅t茅 a effectu茅 une division inverse le 27 juin 2024
  • Les actionnaires ont approuv茅 un nouveau ratio de division inverse de 1 pour 5 脿 1 pour 70 lors de l'assembl茅e annuelle du 20 mai 2025
  • Le conseil d'administration pr茅voit de mettre en 艙uvre une autre division inverse pour retrouver la conformit茅
  • La soci茅t茅 envisage de demander une audience aupr猫s du Nasdaq Hearings Panel

Les actions resteront cot茅es sur le Nasdaq Capital Market en attendant l'issue de l'audience. Cependant, il n'y a aucune garantie de maintien de la cotation ou de r茅tablissement r茅ussi de la conformit茅. Cette situation pr茅sente des risques importants pour les investisseurs, notamment la possibilit茅 de radiation et une dilution suppl茅mentaire des actions via une autre division inverse.

Nuwellis hat am 18. Juni 2025 eine Mitteilung 眉ber die Delistung von der Nasdaq erhalten, da die Mindestgebotspreisanforderung von 1,00 $ f眉r 30 aufeinanderfolgende Handelstage nicht erf眉llt wurde. Das Unternehmen ist aufgrund vorheriger Reverse Stock Splits nicht f眉r die Standard-Compliance-Periode berechtigt.

Wichtige Entwicklungen:

  • Das Unternehmen f眉hrte am 27. Juni 2024 einen Reverse Stock Split durch
  • Die Aktion盲re genehmigten auf der Hauptversammlung am 20. Mai 2025 ein neues Reverse-Split-Verh盲ltnis von 1:5 bis 1:70
  • Der Vorstand beabsichtigt, einen weiteren Reverse Stock Split durchzuf眉hren, um die Compliance wiederherzustellen
  • Das Unternehmen plant, eine Anh枚rung beim Nasdaq Hearings Panel zu beantragen

Die Aktie bleibt bis zum Ergebnis der Anh枚rung an der Nasdaq Capital Market notiert. Es gibt jedoch keine Garantie f眉r eine fortgesetzte Notierung oder die erfolgreiche Wiederherstellung der Compliance. Diese Situation birgt erhebliche Risiken f眉r Investoren, einschlie脽lich einer m枚glichen Delistung und weiterer Verw盲sserung der Aktien durch einen weiteren Reverse Split.

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 8-K

Current Report Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 18, 2025

Nuwellis, Inc.
(Exact Name of Registrant as Specified in its Charter)

Delaware
001-35312
No. 68-0533453
(State or Other Jurisdiction of Incorporation or Organization)
(Commission File Number)
(I.R.S. Employer Identification No.)

12988 Valley View Road, Eden Prairie, MN
(Address of Principal Executive Offices)
  
55344
(Zip Code)

(952) 345-4200
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:


 ☐
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)


☐
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)


☐
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))


☐
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol(s)
Name of each exchange on which
registered
Common Stock, par value $0.0001 per share
NUWE
Nasdaq Capital Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 3.01.
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.
​
On June 18, 2025, Nuwellis, Inc. (the “Company”) received a letter (the “Deficiency Notice”) from the Listing Qualifications Department (the “Staff”) of the Nasdaq Stock Market (“Nasdaq”) informing the Company that because the closing bid price for the Company’s common stock listed on Nasdaq was below $1.00 for 30 consecutive trading days, the Company is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market, as set forth in Nasdaq Marketplace Rule 5550(a)(2) (the “Minimum Bid Price Requirement”).

 The Deficiency Notice also indicated that the Company is not eligible for any compliance period specified in Nasdaq Listing Rule 5810(c)(3)(A) because the Company effected a reverse stock split over the prior one-year period or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one; accordingly, the Company was informed that its securities were subject to delisting from Nasdaq unless the Company timely requested a hearing before the Nasdaq Hearings Panel (the “Panel”). As previously disclosed, the Company effected a reverse stock split of its Common Stock on June 27, 2024.
 
At its annual meeting held on May 20, 2025, the Company’s stockholders approved a proposal allowing the board of directors of the Company to effect a reverse split in the range of 1-for-5 to 1-for-70.  The Company’s board of directors intends to effect a reverse stock split in the near term in order to regain compliance with the Minimum Bid Price Requirement.
 
The Company intends to timely submit a request for a hearing and the Company’s securities will then remain listed and eligible for trading on the Nasdaq Capital Market at least pending the ultimate conclusion of any hearing process.  There can be no assurance that the Panel will grant the Company’s request for continued listing or that the Company will be able to regain compliance and thereafter maintain its listing on Nasdaq.

Cautionary Note Regarding Forward Looking Statements

This Current Report on Form 8-K contains certain forward-looking statements within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act and Private Securities Litigation Reform Act, as amended, and as such are not historical facts. This includes, without limitation, statements regarding the Company’s plans to appeal the Company’s intent or ability to regain compliance with the Minimum Bid Price Requirement, the outcome of a Nasdaq hearing and appeal process, and the anticipated actions by the Nasdaq Staff and the Company’s responses and their anticipated outcome, and the ability for the Company’s securities to remain listed on Nasdaq. These statements constitute projections, forecasts and forward-looking statements, and are not guarantees of performance. Such statements can be identified by the fact that they do not relate strictly to historical or current facts. When used in this communication, words such as “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “strive,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. When the Company discusses its strategies or plans, it is making projections, forecasts or forward-looking statements. Such statements are based on the beliefs of, as well as assumptions made by and information currently available to, the Company’s management. Such factors include those set forth in the Company’s filings with the U.S. Securities and Exchange Commission. Prospective investors are cautioned not to place undue reliance on such forward-looking statements, which speak only as of the date of this press release. The Company undertakes no obligation to publicly update any forward-looking statement, whether as a result of new information, future events or otherwise.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Date: June 23, 2025
NUWELLIS, INC.
   
 
By:
/s/ John L. Erb
  
 
Name:
 John L. Erb
 
Title:
Interim President and Chief Executive Officer


Source:

FAQ

Why did NUWE receive a Nasdaq delisting notice in June 2025?

NUWE received a delisting notice from Nasdaq on June 18, 2025, because its stock price closed below $1.00 for 30 consecutive trading days, violating Nasdaq's minimum bid price requirement (Rule 5550(a)(2)). The company is not eligible for a standard compliance period due to previous reverse stock splits.

What is NUWE's plan to maintain Nasdaq listing after the June 2025 deficiency notice?

NUWE plans to: 1) Request a hearing before the Nasdaq Hearings Panel to maintain temporary listing status, and 2) Implement a new reverse stock split, which was approved by stockholders on May 20, 2025, in a range of 1-for-5 to 1-for-70 to regain compliance with the minimum bid price requirement.

When did NUWE last perform a reverse stock split before the 2025 delisting notice?

NUWE previously executed a reverse stock split of its Common Stock on June 27, 2024, which affects their eligibility for a standard compliance period under Nasdaq listing rules.

Who is currently leading NUWE as CEO in 2025?

John L. Erb is serving as Interim President and Chief Executive Officer of Nuwellis, Inc., as evidenced by his signature on the June 23, 2025 filing.

Will NUWE stock continue trading on Nasdaq after receiving the deficiency notice?

NUWE's securities will remain listed and eligible for trading on the Nasdaq Capital Market at least until the conclusion of the hearing process. However, the company notes there is no assurance the Panel will grant continued listing or that NUWE will maintain its Nasdaq listing thereafter.
Stock NUWE logo
Nuwellis Inc

NASDAQ:NUWE

NUWE Rankings

#7500 Ranked by Market Cap
N/A Ranked by Dividends

NUWE Latest News

Aug 4, 2025
Nuwellis Stockholders Approve All Proposals at Special Meeting
Jul 23, 2025
Nuwellis Participates in the Virtual Investor 鈥淲hat鈥檚 Your Story鈥� Summer Spotlight On-Demand Conference
Jul 23, 2025
Nuwellis Regains Compliance with Nasdaq Listing Requirements
Jul 22, 2025
Nuwellis, Inc. To Report Second Quarter 2025 Financial Results on August 12, 2025
Jul 17, 2025
Nuwellis Announces Termination of REVERSE-HF Clinical Trial to Focus on Strategic Growth in Outpatient Heart Failure Care

NUWE Latest SEC Filings

Aug 4, 2025
[8-K] Nuwellis, Inc. Reports Material Event
Jul 23, 2025
[8-K] Nuwellis, Inc. Reports Material Event
Jul 14, 2025
[DEF 14A] Nuwellis, Inc. Definitive Proxy Statement
Jul 3, 2025
[PRE 14A] Nuwellis, Inc. Preliminary Proxy Statement
Jul 2, 2025
[8-K] Nuwellis, Inc. Reports Material Event

NUWE Stock Data

1.51M
526.33k
5.01%
1.7%
59.42%
Medical Devices
Electromedical & Electrotherapeutic Apparatus
United States
EDEN PRAIRIE